Brian E. Mcdowell

Array ( [id] => 34067 [patent_doc_number] => 07786297 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Purified form of tanaproget' [patent_app_type] => utility [patent_app_number] => 11/412016 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6130 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/786/07786297.pdf [firstpage_image] =>[orig_patent_app_number] => 11412016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210187 [patent_doc_number] => 20070248771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Acenaphtho[1,2-b]quinoxaline sulfo-and carboxy-derivative, lyotropic liquid crystal system, optically anisotropic film and method thereof and laminated optical film' [patent_app_type] => utility [patent_app_number] => 11/408357 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2950 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248771.pdf [firstpage_image] =>[orig_patent_app_number] => 11408357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5136506 [patent_doc_number] => 20070078135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Substituted heteroaryl CB1 antagonists' [patent_app_type] => utility [patent_app_number] => 11/406532 [patent_app_country] => US [patent_app_date] => 2006-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43785 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078135.pdf [firstpage_image] =>[orig_patent_app_number] => 11406532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000394 [patent_doc_number] => 20070043028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Compositions of novel opioid compounds and method of use thereof' [patent_app_type] => utility [patent_app_number] => 11/404632 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48064 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043028.pdf [firstpage_image] =>[orig_patent_app_number] => 11404632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205668 [patent_doc_number] => 20070027150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => '2-Amino-quinazolin-5-ones' [patent_app_type] => utility [patent_app_number] => 11/404372 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28691 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027150.pdf [firstpage_image] =>[orig_patent_app_number] => 11404372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016853 [patent_doc_number] => 20070260062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Heterocyclical Chromophore Architectures with Novel Electronic Acceptor Systems' [patent_app_type] => utility [patent_app_number] => 11/666269 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4450 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20070260062.pdf [firstpage_image] =>[orig_patent_app_number] => 11666269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515544 [patent_doc_number] => 20090215851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Method of Preparing a Porphyrin Derivative, a Porphyrin Derivative, Use of Said Porphyrin derivative and a pharmaceutical composition containing said porphyrin derivative' [patent_app_type] => utility [patent_app_number] => 11/885848 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7976 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215851.pdf [firstpage_image] =>[orig_patent_app_number] => 11885848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564762 [patent_doc_number] => 20090137615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'INDAZOLYLAMINO QUINAZOLINE DERIVATIVES AS ANTITUMOUR AGENTS' [patent_app_type] => utility [patent_app_number] => 11/817393 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23365 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137615.pdf [firstpage_image] =>[orig_patent_app_number] => 11817393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 133015 [patent_doc_number] => 07696215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => '4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases' [patent_app_type] => utility [patent_app_number] => 11/817137 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26109 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696215.pdf [firstpage_image] =>[orig_patent_app_number] => 11817137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5528377 [patent_doc_number] => 20090198454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'STANDARD SAMPLE FOR TEST AND /OR CALIBRATION OF CIRCULAR DICHROISM DISPERSION METER AND UV-VISIBLE SPECTROPHOTOMETER' [patent_app_type] => utility [patent_app_number] => 12/064786 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8737 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20090198454.pdf [firstpage_image] =>[orig_patent_app_number] => 12064786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398466 [patent_doc_number] => 08268845 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Tetrahydro- and dihydroquinazolinones' [patent_app_type] => utility [patent_app_number] => 11/908220 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36769 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11908220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688991 [patent_doc_number] => 20060287306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Compounds to treat alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 11/345660 [patent_app_country] => US [patent_app_date] => 2006-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33815 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287306.pdf [firstpage_image] =>[orig_patent_app_number] => 11345660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753238 [patent_doc_number] => 20080161313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Diazabicyclononene Derivatives and Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/795850 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6111 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161313.pdf [firstpage_image] =>[orig_patent_app_number] => 11795850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875137 [patent_doc_number] => 20060166861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Inclusion compound of porphyrin metal complex and albumin' [patent_app_type] => utility [patent_app_number] => 11/337473 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4916 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166861.pdf [firstpage_image] =>[orig_patent_app_number] => 11337473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490889 [patent_doc_number] => 20090291960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'PYRROLINIDIUM DERIVATIVES AS M3 MUSCARINIC RECEPTORS' [patent_app_type] => utility [patent_app_number] => 11/721058 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8375 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291960.pdf [firstpage_image] =>[orig_patent_app_number] => 11721058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5597083 [patent_doc_number] => 20060161001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Substituted heterocyclic compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 11/312292 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36839 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20060161001.pdf [firstpage_image] =>[orig_patent_app_number] => 11312292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4535092 [patent_doc_number] => 07872124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Dipeptidyl peptidase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/305818 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 34257 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/872/07872124.pdf [firstpage_image] =>[orig_patent_app_number] => 11305818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693927 [patent_doc_number] => 20070015759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Metasubstituted thiazolidinones, their manufacture and use as a drug' [patent_app_type] => utility [patent_app_number] => 11/302537 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 91683 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015759.pdf [firstpage_image] =>[orig_patent_app_number] => 11302537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894053 [patent_doc_number] => 20080103152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Novel Diazabicyclononene Derivative' [patent_app_type] => utility [patent_app_number] => 11/792728 [patent_app_country] => US [patent_app_date] => 2005-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6207 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103152.pdf [firstpage_image] =>[orig_patent_app_number] => 11792728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596872 [patent_doc_number] => 20060160790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Thioureas as factor Xa inhibitors' [patent_app_type] => utility [patent_app_number] => 11/298296 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18302 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160790.pdf [firstpage_image] =>[orig_patent_app_number] => 11298296 [rel_patent_id] =>[rel_patent_doc_number] =>)